Federal obligations in biotechnology R&D except nanobiotechnology (NAICS 541714)

What 541714 covers and excepts

NAICS 541714 is research and development in biotechnology except nanobiotechnology. On USAspending.gov the code tags contract awards classified that way: contracted biotech research that contracting officers place on the current split code. It is not a count of clinical trials, and it is not manufacturing of licensed biologicals (325414). Nanobiotechnology, by the title, is supposed to sit elsewhere.

The older biotechnology R&D code is 541711. Physical, engineering, and life sciences R&D except biotech is 541712; except nano and biotech is 541715. A countermeasure program can buy research under 541714 and doses under 325414. The $19.0 billion figure is only awards tagged 541714. Do not add 541714 to 541711 as one industry without checking how awards were tagged.

Reading $19.0 billion in biotech-research obligations

USAspending records obligations on contract awards tagged 541714. Incremental funding, task orders, and modifications all feed $19,013,172,722.03. This packet has no fiscal-year split and no outlay total. Much biomedical funding still moves as grants, which often have no NAICS.

Outlays are the payments. Quote $19.0 billion as USAspending contract obligations coded to NAICS 541714. Do not describe it as the NIH budget or as cash already spent. This page does not offer medical advice.

2,378 awards, not 2,378 laboratories

The 2,378 award records are contract actions, including modifications. The count is not 2,378 biotech firms. Compared with the older 541711 line in this industry set, 541714 shows more records—consistent with a current split code used on more vehicles. Open the industry page for the award list.

Biotech research has two contract NAICS lines in this warehouse, and mixing them is the standard error. This page is 541714 only: $19,013,172,722.03 in USAspending obligations on 2,378 awards, biotechnology R&D except nanobiotechnology. The older 541711 line has its own facts. Manufacturing of biological products is 325414. Physical-sciences R&D that excepts biotech is 541715 or 541712. Grants often have no NAICS and will underfill any industry table. The 2,378 records are contract actions, not laboratories and not trials. This page is not medical advice. Quote the except-nanobiotechnology qualifier. Quote obligations, not outlays. Use the industry page for award IDs.

Grants and manufacturing neighbors

Assistance awards often lack NAICS and are outside $19,013,172,722.03. Biological-product manufacturing (325414) is production, not this R&D line. Pharmaceutical preparations (325412) are finished-dose drugs. Social-science R&D is 541720. Keep those tables separate.

SpendingVault aggregates USAspending.gov contract data. The dollar total and the 2,378 award count can change after corrections. The live industry page is the table of record.

Using the 541714 industry page

Open the RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) industry page for the award list under the headline. Keep 541714 distinct from 541711 and from the physical-sciences R&D codes on All industries. Cite obligations, not outlays, and keep the except-nanobiotechnology qualifier in the name.

Citing 541714 without merging 541711 or manufacturing

Cite $19,013,172,722.03 in USAspending obligations on 2,378 awards tagged NAICS 541714, biotechnology R&D except nanobiotechnology. Keep the except clause. Do not add the older 541711 line. Do not add biological-product manufacturing.

The 2,378 award count is not laboratories. Grants often have no NAICS. This page is not medical advice and not an NIH budget. Outlays are not in the packet. If research was tagged 541715 instead because the officer did not use a biotech code, those dollars will not appear here.

541714 is the current biotech-research split with nanobiotechnology carved out. The $19,013,172,722.03 total is awards tagged that way, 2,378 of them. A countermeasure research vehicle and a smaller biotech study can share the code. Manufacturing of the resulting product, if tagged 325414, will not share it. The older 541711 line will not share it unless the award still carries 541711.

Clinical-trial counts, patents, and NIH appropriations are not in this packet. Grants often have no NAICS. This page is not medical advice. Cite USAspending obligations on 2,378 awards coded 541714, biotechnology R&D except nanobiotechnology. Keep the except clause. Keep outlays out. Use the industry table for award IDs.

Questions

How much is obligated on NAICS 541714 biotechnology R&D?

USAspending.gov contract awards coded NAICS 541714 show $19,013,172,722.03 in obligations across 2,378 awards. That total is obligations, not outlays, for biotechnology R&D except nanobiotechnology. USAspending.gov records the amount as contract obligations, not outlays, on awards tagged NAICS 541714.

How is 541714 different from 541711?

541714 is the current biotechnology R&D code except nanobiotechnology. 541711 is the older biotechnology R&D line. This page reports only $19,013,172,722.03 on 541714. Do not merge the codes as one industry. The packet total is $19,013,172,722.03 across 2,378 awards; assistance awards often have no NAICS and stay outside the industry rollup.

Does 541714 include vaccine manufacturing?

Biological product manufacturing is NAICS 325414. 541714 is research and development. Manufacturing dollars tagged 325414 are not inside the $19,013,172,722.03 total. Treat the 2,378 figure as an award-record count, including orders and modifications, not as a physical inventory of products or sites.

Are NIH grants included?

Assistance awards may not carry NAICS and are generally outside this industry total. The 2,378 awards are contract records tagged 541714, not a grant inventory. This guide does not add a fiscal-year split. Quote the live industry page if you need the current award list under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY).